Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ERGONYSEAMERICAN:GNS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeERGOEntia Biosciences$0.00$0.00▼$0.00N/A12.3150 shsN/AGNSGenius Group$0.37-4.7%$0.31$0.21▼$5.69$2.71M10.452.75 million shs1.86 million shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceERGOEntia Biosciences0.00%0.00%0.00%0.00%0.00%GNSGenius Group-2.78%+38.54%+45.12%-22.25%-90.18%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationERGOEntia BiosciencesN/AN/AN/AN/AN/AN/AN/AN/AGNSGenius Group0.8572 of 5 stars0.04.00.00.00.01.71.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceERGOEntia Biosciences 0.00N/AN/AN/AGNSGenius Group 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookERGOEntia BiosciencesN/AN/AN/AN/AN/AN/AGNSGenius Group$23.06M0.12N/AN/A$2.67 per share0.14Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateERGOEntia BiosciencesN/AN/A0.00N/AN/AN/AN/AN/AN/AGNSGenius Group-$5.66MN/A0.00N/AN/AN/AN/AN/A5/21/2025 (Estimated)Latest OXB, ONT, GNS, and ERGO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/21/2025H2 2024GNSGenius Group-$0.05N/AN/AN/A$12.85 millionN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthERGOEntia BiosciencesN/AN/AN/AN/AN/AGNSGenius GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioERGOEntia BiosciencesN/AN/AN/AGNSGenius Group0.022.522.48Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipERGOEntia BiosciencesN/AGNSGenius Group14.28%Insider OwnershipCompanyInsider OwnershipERGOEntia Biosciences28.30%GNSGenius Group51.19%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableERGOEntia Biosciences6N/AN/ANot OptionableGNSGenius Group4807.39 million3.61 millionNot OptionableOXB, ONT, GNS, and ERGO HeadlinesRecent News About These CompaniesGenius Group Reports Strong NAV Growth Amid ChallengesMay 1 at 12:42 AM | tipranks.comGenus FDA green light a “hugely significant landmark"April 30 at 10:02 AM | proactiveinvestors.co.ukGenius Group Announces 2024 Financial Results, 303% NAV GrowthApril 30 at 8:15 AM | globenewswire.comGenius Group to Release Full Year 2024 Results and Host Investor Webcast on April 30, 2025April 25, 2025 | globenewswire.comGenius Group Restructures Bitcoin Holdings Amid Legal BattleApril 11, 2025 | tipranks.comGenius Group approves share buyback for 20% of issued sharesApril 9, 2025 | markets.businessinsider.comGenius Group Approves 20% Share Buyback Amid Legal ChallengesApril 9, 2025 | tipranks.comGenius Group files RICO lawsuit agains Michael Moe, Peter RitzApril 5, 2025 | markets.businessinsider.comGenius Group Files $450 Million RICO Lawsuit Against Moe and RitzApril 4, 2025 | tipranks.comGenius Group Files RICO Lawsuit Against LZGI's Peter Ritz, Michael Moe Seeking $450 Mln In DamagesApril 4, 2025 | finanznachrichten.deGenius Group files RICO lawsuit against Michael Moe and Peter Ritz, seeks over $450 million in damagesApril 4, 2025 | markets.businessinsider.comGenius Group blocked from raising funds, buying bitcoin by NY courtApril 4, 2025 | markets.businessinsider.comNew York court vetoes Genius Group’s plan to raise funds for Bitcoin purchaseApril 3, 2025 | cryptopolitan.comGenius Group CEO says ‘will not bend’ to fraudsters, market manipulatorsApril 3, 2025 | markets.businessinsider.comGenius Group Faces Legal and Financial Hurdles Amid Court InjunctionApril 3, 2025 | tipranks.comGenius Group Blocked from Raising Funds and Buying Bitcoin by New York CourtApril 3, 2025 | globenewswire.comGenius Group LTD trading resumesMarch 20, 2025 | markets.businessinsider.comGenius Group LTD trading halted, news pendingMarch 19, 2025 | markets.businessinsider.comGenius Group files appeal to vacate preliminary injunctionMarch 19, 2025 | markets.businessinsider.comGenius Group Appeals Court Ruling on Stock InjunctionMarch 19, 2025 | tipranks.comNew MarketBeat Followers Over TimeTop HeadlinesView All HeadlinesGold Rally Continues: These 3 Mining Stocks Are Likely to BenefitBy Chris Markoch | April 16, 2025View Gold Rally Continues: These 3 Mining Stocks Are Likely to BenefitNVIDIA Stock: Oversold, Undervalued — How Low Can It Go?By Thomas Hughes | April 7, 2025View NVIDIA Stock: Oversold, Undervalued — How Low Can It Go?NVIDIA vs Qualcomm: Which Is the Better Buy for Q2?By Sam Quirke | April 3, 2025View NVIDIA vs Qualcomm: Which Is the Better Buy for Q2?Best Gold Stocks in 2025… So FarBy Dan Schmidt | April 3, 2025View Best Gold Stocks in 2025… So FarThese 3 Stocks Have Huge Last 12 Months Shareholder YieldsBy Leo Miller | April 18, 2025View These 3 Stocks Have Huge Last 12 Months Shareholder YieldsOXB, ONT, GNS, and ERGO Company DescriptionsEntia Biosciences OTCMKTS:ERGOEntia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical foods, nutraceuticals, cosmetics, and other products. The company's portfolio of formulations include ErgoD2, a pharmaceutical grade organic compound from whole food that contains the micro-nutrients; L-Ergothioneine, a naturally occurring amino acid and master antioxidant; and vitamin D, an antioxidant. In addition, it is also developing products for the chronic kidney disease and other diseases, as well as providing cosmeceuticals and other beauty products under the GROH brand name. Entia Biosciences, Inc. offers its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was founded in 2007 and is headquartered in Sherwood, Oregon.Genius Group NYSEAMERICAN:GNS$0.37 -0.02 (-4.70%) As of 04:10 PM EasternGenius Group Limited, through its subsidiaries, provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company operates through two segments, Education and Campus. It develops comprehensive entrepreneurial education curriculum with a full suite of tools for student learning and faculty earning. The company also owns entrepreneur resorts in Bali and South Africa, which run entrepreneur retreats and workshops; and Genius Café, an entrepreneur beach club in Bali, as well as Genius Central, an entrepreneur co-working hub in Singapore. In addition, it offers home childcare and investment education services; operates entrepreneur education campus that provides a range of programs from pre-primary through primary school, secondary school, and vocational college; and provides career-focused on-campus and online programs at the master's, bachelor's and associate degree level, as well as certificate and continuing education programs. The company operates in Europe/the Middle East/Africa, the Asia/Pacific, and North America/South America. Genius Group Limited was founded in 2002 and is headquartered in Singapore. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Hims & Hers Stock Soars on Novo Nordisk Collaboration 3 Dividend Kings Outshining the Market in 2025 Tesla's Band-Aid Has Been Ripped Off: Rally Mode Engaged Amazon's Earnings Will Make or Break the Stock's Comeback Why D-Wave's Project With Davidson Is a Game-Changer For Quantum NXP Semiconductors: A Buy-and-Hold Stock in the Buy Zone Joby Aviation Shares Eye Breakout After Transition Flight Win Altria’s Resilient Strategy Keeps It a Top Dividend Play in 2025 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
